Prevalence of Extra-oesophageal Manifestations in Gastro-oesophageal Reflux Disease: an Analysis Based on the ProGERD Study
Overview
Pharmacology
Authors
Affiliations
Background And Aims: Gastro-oesophageal reflux disease (GERD) can be associated with a variety of extra-oesophageal disorders (EED) such as chronic cough, asthma, laryngeal disorder or chest pain. The aim of the study was to estimate and compare the prevalence of EED in a population with symptomatic GERD presenting as either erosive reflux disease (ERD) or non-erosive reflux disease (NERD).
Methods: Baseline data were collected from a prospective, multicentre, open cohort study (ProGERD) in which patients will be followed for 5 years after initial treatment with esomeprazole. Within the framework of this trial, all patients underwent gastroscopy and filled out a questionnaire designed to assess EED. The influence of potential prognostic factors on the prevalence of EED was analysed by multivariate (stepwise logistic regression) analysis.
Results: 6215 patients (3303 male, 2912 female; mean age 54 years) presenting with heartburn were included. EED was detected in 32.8% of all patients. The proportion was significantly higher (P = 0.0002) in ERD patients (34.9%) than in NERD patients (30.5%). As judged from the multivariate analysis, female gender, age, oesophagitis of LA grade C/D, duration of GERD disease greater than 1 years and smoking were significantly associated with EED. ERD patients with oesophagitis of LA grade A or B did not have a significantly higher risk of EED than patients with NERD.
Conclusions: Patients with GERD have a high probability of experiencing EED, which may be associated with a number of prognostic factors such as duration and severity of GERD. Extra-oesophageal disorders are slightly, but statistically, more prevalent in ERD than in NERD patients.
Yao P, Liao X, Huang J, Dang Y, Jiang H Medicine (Baltimore). 2024; 103(7):e37054.
PMID: 38363933 PMC: 10869099. DOI: 10.1097/MD.0000000000037054.
Masood M, Low D, Deal S, Kozarek R J Clin Med. 2023; 12(17).
PMID: 37685616 PMC: 10488124. DOI: 10.3390/jcm12175543.
Fossmark R, Ness-Jensen E, Sordal O BMC Gastroenterol. 2023; 23(1):303.
PMID: 37674110 PMC: 10483799. DOI: 10.1186/s12876-023-02945-7.
Pathogenesis and management of gastroesophageal reflux disease-associated cough: a narrative review.
Zhang L, Aierken A, Zhang M, Qiu Z J Thorac Dis. 2023; 15(4):2314-2323.
PMID: 37197515 PMC: 10183548. DOI: 10.21037/jtd-22-1757.
Trends in gastroesophageal reflux disease research: A bibliometric and visualized study.
Zhang T, Zhang B, Tian W, Wei Y, Wang F, Yin X Front Med (Lausanne). 2022; 9:994534.
PMID: 36250094 PMC: 9556905. DOI: 10.3389/fmed.2022.994534.